Category Archives: Plavix

Subscribe to Plavix RSS Feed

State Attorney General Files Lawsuit Against Plavix® Manufacturers

Posted in Plavix

As we have previously reported, the makers of Plavix®, Sanofi-Aventis and Bristol-Myers Squibb, have been fined for engaging in anti-competitive behavior related to the sale and marketing of the medication. Plavix® is a blood thinner prescribed to prevent heart attacks, strokes and blood clotting. However, the users of Plavix® have alleged various forms of severe… Continue Reading

Sanofi Pharmaceuticals Fined for Anti-Competitive Scheme

Posted in Defective Drugs, Plavix

As we have previously reported, Plavix®, manufactured by Sanofi-Aventis and Bristol-Myers Squibb (collectively, “Defendants”), is a blood thinner prescribed to prevent heart attacks, strokes and blood clotting. However, the users of Plavix® have alleged various forms of severe side-effects. Reportedly, these side-effects include: gastrointestinal bleeding, cerebral bleeding, bleeding ulcers, Thrombotic Thrombocytopenic Purpura (TTP), heart attack,… Continue Reading

New Study Suggests Plavix May Increase the Risk of Heart Attack or Stroke

Posted in Defective Drugs, Plavix

Plavix®, marketed by Bristol-Myers Squibb and Sanofi Pharmaceuticals, is the second most commonly prescribed drug on the U.S. market to prevent heart attacks and stroke.  The medication, known as a “clopidogrel,” is a blood thinner that belongs to a category of drugs called antiplatelets.  The drug works to prevent blood clots.  A recent study by… Continue Reading

The United States Department of Justice is Concerned with Plavix®

Posted in Defective Drugs, Plavix

The United States Department of Justice (“DOJ”) is concerned that the dangers of Plavix® were not properly identified by its manufacturers Sanofi-Aventis and Bristol-Myers Squibb.  The DOJ is concerned that the manufacturers failed to disclose certain information in hopes of misleading consumers about the safety of the drug.  Studies show that certain individuals have a… Continue Reading

Plavix Hemorrhaging Litigation Continues in New Jersey

Posted in Defective Drugs, Plavix

Plavix, manufactured by Sanofi-Aventis and Bristol-Myers Squibb (collectively, “Defendants”), is a blood thinner prescribed to prevent heart attacks, strokes and blood clotting. However, the users of Plavix have alleged various forms of severe side-effects. Reportedly, these side-effects include: gastrointestinal bleeding, cerebral bleeding, bleeding ulcers, Thrombotic Thrombocytopenic Purpura (TTP), heart attack, stroke and death. In February… Continue Reading